255 filings
Page 4 of 13
4
TSHA
Taysha Gene Therapies Inc
26 Jun 23
Taysha Gene Therapies / R.A. Session II ownership change
4:46pm
8-K
TSHA
Taysha Gene Therapies Inc
23 Jun 23
Submission of Matters to a Vote of Security Holders
5:27pm
8-K
TSHA
Taysha Gene Therapies Inc
22 Jun 23
Departure of Directors or Certain Officers
5:12pm
4
Session R.A. II
22 Jun 23
Taysha Gene Therapies / R.A. Session II ownership change
4:00pm
144/A
Session R.A. II
20 Jun 23
Notice of proposed sale of securities (amended)
7:14pm
144
TSHA
Taysha Gene Therapies Inc
20 Jun 23
Notice of proposed sale of securities
4:52pm
8-K
TSHA
Taysha Gene Therapies Inc
6 Jun 23
Departure of Directors or Certain Officers
4:02pm
8-K
TSHA
Taysha Gene Therapies Inc
5 Jun 23
Taysha Gene Therapies Announces First Patient Dosed with TSHA-102 in the REVEAL Phase 1/2 Trial
8:20am
4
Kamran Alam
2 Jun 23
Taysha Gene Therapies / Kamran Alam ownership change
4:12pm
144
TSHA
Taysha Gene Therapies Inc
1 Jun 23
Notice of proposed sale of securities
9:25pm
144
Porter Fred
1 Jun 23
Notice of proposed sale of securities
9:24pm
8-K
TSHA
Taysha Gene Therapies Inc
19 May 23
Other Events
8:28am
4
TSHA
Taysha Gene Therapies Inc
18 May 23
Taysha Gene Therapies / Sukumar Nagendran ownership change
4:44pm
8-K
TSHA
Taysha Gene Therapies Inc
15 May 23
Taysha Gene Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
5:13pm
144
McGinnis Emily
11 May 23
Notice of proposed sale of securities
6:15pm
10-Q
2023 Q1
TSHA
Taysha Gene Therapies Inc
Quarterly report
11 May 23
4:38pm
ARS
2022 FY
TSHA
Taysha Gene Therapies Inc
8 May 23
Annual report to shareholders
4:07pm
DEFA14A
TSHA
Taysha Gene Therapies Inc
8 May 23
Additional proxy soliciting materials
4:04pm
DEF 14A
TSHA
Taysha Gene Therapies Inc
Definitive proxy
8 May 23
4:01pm
424B3
TSHA
Taysha Gene Therapies Inc
4 May 23
Prospectus supplement
4:02pm